We’re pleased to inform you that effective April 20th, 2026, Axis will be updating our Comprehensive Panel with Analyte Assurance™ and offering a new Orphine Analog Panel.
What is Changing?
For orders placed on or after April 20th, 2026, the 70510 Comprehensive Panel, Blood will include the following added analytes:
- alpha-PHPP (PV8) – Confirmed via 13710: Novel Emerging Compounds Panel
- alpha-PiHPP (Iso-PV8) – Confirmed via 13710: Novel Emerging Compounds Panel
- alpha-PipHP – Confirmed via 13710: Novel Emerging Compounds Panel
- Ethylbromazolam – Confirmed via 13510: Designer Benzodiazepine Panel
- Mitragynine Pseudoindoxyl – Confirmed via 13710: Novel Emerging Compounds Panel
- N-Pyrrolidino Ethylene Isotonitazene – Confirmed via 13910: Nitazene Analog Panel
- N-Pyrrolidino Isotonitazene – Confirmed via 13910: Nitazene Analog Panel
- Phenazolam – Confirmed via 13510: Designer Benzodiazepine Panel
- Suzetrigine – Provided as part of 70510: Comprehensive Panel, Blood
Additionally, with the rise of “Orphines” throughout the United States, Axis will be offering a new 13410: Orphine Analog Panel, Blood. As with other emerging and designer type panels, the screening for these analytes will be included as part of Analyte Assurance in the 70510: Comprehensive Panel, Blood. The components of this panel are detailed below.
- 5,6-Dichloro Brorphine
- 5,6-Dichloro Desmethylchlorphine
- Brorphine
- Chlorphine
- N-Propionitrile Chlorphine (Cychlorphine)
- Spirobrorphine
- Spirochlorphine
What Do You Need to Do?
You do not need to do anything different as these analytes will automatically be included with your 70510: Comprehensive Panel, Blood order under Analyte Assurance. For a copy of the new specification sheet that is effective April 20th, 2026 please click this link: https://axisfortox.com/test_catalog/comprehensive-drug-panel/
At Axis Forensic Toxicology, we are committed to evolving with the needs of our clients and the ever-changing landscape of emerging substances. These additions reflect our proactive approach to ensuring you receive the most comprehensive and reliable testing services available.
If you have any questions or would like more information regarding this update, please don’t hesitate to reach out to us at [email protected]. Our team is always ready to assist.
Thank you for your continued partnership and trust in Axis. We look forward to continuing to support your work with the highest quality service and testing solutions.
Sincerely,
Matt Zollman
Director of Operations & Product Management